Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease

Masahiko Fujihara, Mitsuhiro Fukata, Keita Odashiro, Toru Maruyama, Koichi Akashi, Yoshiaki Yokoi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

A reduced ratio of plasma eicosapentaenoic acid-arachidonic acid (EPA-AA) is a newly recognized atherosclerotic risk factor. This ratio has not been fully investigated in peripheral artery disease (PAD). Seventy Japanese patients with atherosclerotic risk factors were enrolled and divided into 2 groups, those with PAD (group A: n = 38) and those without PAD (group B: n = 32). The EPA-AA ratio (P =.001) and ankle-brachial index (ABI: P <.001) in group A were significantly lower than those in group B. Univariate and multivariate analyses demonstrated that EPA-AA, ABI, and prescription of clopidogrel had significant correlation with PAD. Given the appropriate cutoff values, EPA-AA (odds ratio [OR] = 11.7, 95% confidence interval [CI] = 3.0-45.8; P <.001) and ABI (OR = 44.0, 95% CI = 5.4-358.5; P <.001) are factors independently associated with PAD. In conclusion, this study demonstrated that reduced plasma EPA/AA may underlie PAD at least in Japanese.

Original languageEnglish
Pages (from-to)112-118
Number of pages7
JournalAngiology
Volume64
Issue number2
DOIs
Publication statusPublished - Jan 1 2013

Fingerprint

Eicosapentaenoic Acid
Peripheral Arterial Disease
Arachidonic Acid
clopidogrel
Odds Ratio
Confidence Intervals
Ankle Brachial Index
Prescriptions
Multivariate Analysis

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cite this

Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease. / Fujihara, Masahiko; Fukata, Mitsuhiro; Odashiro, Keita; Maruyama, Toru; Akashi, Koichi; Yokoi, Yoshiaki.

In: Angiology, Vol. 64, No. 2, 01.01.2013, p. 112-118.

Research output: Contribution to journalArticle

Fujihara, Masahiko ; Fukata, Mitsuhiro ; Odashiro, Keita ; Maruyama, Toru ; Akashi, Koichi ; Yokoi, Yoshiaki. / Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease. In: Angiology. 2013 ; Vol. 64, No. 2. pp. 112-118.
@article{cf12297a5fad4678aea229af1d136f2b,
title = "Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease",
abstract = "A reduced ratio of plasma eicosapentaenoic acid-arachidonic acid (EPA-AA) is a newly recognized atherosclerotic risk factor. This ratio has not been fully investigated in peripheral artery disease (PAD). Seventy Japanese patients with atherosclerotic risk factors were enrolled and divided into 2 groups, those with PAD (group A: n = 38) and those without PAD (group B: n = 32). The EPA-AA ratio (P =.001) and ankle-brachial index (ABI: P <.001) in group A were significantly lower than those in group B. Univariate and multivariate analyses demonstrated that EPA-AA, ABI, and prescription of clopidogrel had significant correlation with PAD. Given the appropriate cutoff values, EPA-AA (odds ratio [OR] = 11.7, 95{\%} confidence interval [CI] = 3.0-45.8; P <.001) and ABI (OR = 44.0, 95{\%} CI = 5.4-358.5; P <.001) are factors independently associated with PAD. In conclusion, this study demonstrated that reduced plasma EPA/AA may underlie PAD at least in Japanese.",
author = "Masahiko Fujihara and Mitsuhiro Fukata and Keita Odashiro and Toru Maruyama and Koichi Akashi and Yoshiaki Yokoi",
year = "2013",
month = "1",
day = "1",
doi = "10.1177/0003319712437031",
language = "English",
volume = "64",
pages = "112--118",
journal = "Angiology",
issn = "0003-3197",
publisher = "SAGE Publications Inc.",
number = "2",

}

TY - JOUR

T1 - Reduced plasma eicosapentaenoic acid-arachidonic acid ratio in peripheral artery disease

AU - Fujihara, Masahiko

AU - Fukata, Mitsuhiro

AU - Odashiro, Keita

AU - Maruyama, Toru

AU - Akashi, Koichi

AU - Yokoi, Yoshiaki

PY - 2013/1/1

Y1 - 2013/1/1

N2 - A reduced ratio of plasma eicosapentaenoic acid-arachidonic acid (EPA-AA) is a newly recognized atherosclerotic risk factor. This ratio has not been fully investigated in peripheral artery disease (PAD). Seventy Japanese patients with atherosclerotic risk factors were enrolled and divided into 2 groups, those with PAD (group A: n = 38) and those without PAD (group B: n = 32). The EPA-AA ratio (P =.001) and ankle-brachial index (ABI: P <.001) in group A were significantly lower than those in group B. Univariate and multivariate analyses demonstrated that EPA-AA, ABI, and prescription of clopidogrel had significant correlation with PAD. Given the appropriate cutoff values, EPA-AA (odds ratio [OR] = 11.7, 95% confidence interval [CI] = 3.0-45.8; P <.001) and ABI (OR = 44.0, 95% CI = 5.4-358.5; P <.001) are factors independently associated with PAD. In conclusion, this study demonstrated that reduced plasma EPA/AA may underlie PAD at least in Japanese.

AB - A reduced ratio of plasma eicosapentaenoic acid-arachidonic acid (EPA-AA) is a newly recognized atherosclerotic risk factor. This ratio has not been fully investigated in peripheral artery disease (PAD). Seventy Japanese patients with atherosclerotic risk factors were enrolled and divided into 2 groups, those with PAD (group A: n = 38) and those without PAD (group B: n = 32). The EPA-AA ratio (P =.001) and ankle-brachial index (ABI: P <.001) in group A were significantly lower than those in group B. Univariate and multivariate analyses demonstrated that EPA-AA, ABI, and prescription of clopidogrel had significant correlation with PAD. Given the appropriate cutoff values, EPA-AA (odds ratio [OR] = 11.7, 95% confidence interval [CI] = 3.0-45.8; P <.001) and ABI (OR = 44.0, 95% CI = 5.4-358.5; P <.001) are factors independently associated with PAD. In conclusion, this study demonstrated that reduced plasma EPA/AA may underlie PAD at least in Japanese.

UR - http://www.scopus.com/inward/record.url?scp=84872582809&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872582809&partnerID=8YFLogxK

U2 - 10.1177/0003319712437031

DO - 10.1177/0003319712437031

M3 - Article

C2 - 22371626

AN - SCOPUS:84872582809

VL - 64

SP - 112

EP - 118

JO - Angiology

JF - Angiology

SN - 0003-3197

IS - 2

ER -